How Patients Are Changing Clinical Trials

In September, the Food and Drug Administration (FDA) approved a controversial drug to treat Duchenne muscular dystrophy, a rare but deadly disease that affects boys. That was a reversal from six months earlier, when an FDA advisory committee had recommended against the drugā€™s approval and said it was not effective, Forbes reported. What tipped the…

The post How Patients Are Changing Clinical Trials appeared first on Next Avenue.

x

Originally posted 2017-05-17 08:15:59.